Publications - 'I'
Publications 151 - 175 de 2447
| Titre | DOI |
|---|---|
|
IEEE VTS Motor Vehicles Challenge 2018-Energy Management of a Range Extender Electric Vehicle C. Depature; S. Pagerit; L. Boulon; S. Jemei; A. Rousseau; A. Bouscayrol 2017 |
|
|
IEEE VTS Motor Vehicles Challenge 2019 Energy Management of a dual-mode locomotive W. Lhomme; T. Letrouve; L. Boulon; S. Jemei; A. Bouscayrol; F. Chauvet; F. Tournez 2018 |
|
|
IEEE VTS Motor Vehicles Challenge 2019 Energy Management of a dual-mode locomotive W. Lhomme; T. Letrouve; L. Boulon; S. Jemei; A. Bouscayrol; F. Chauvet; F. Tournez 2018 |
|
|
IEEE VTS Motor Vehicles Challenge 2020-Energy Management of a Fuel Cell/Ultracapacitor/Lead-Acid Battery Hybrid Electric Vehicle J. Solano; S. Jemei; L. Boulon; L. Silva; D. Hissel; M.C. Pera 2019 |
|
|
IEEE VTS Motor Vehicles Challenge 2020-Energy Management of a Fuel Cell/Ultracapacitor/Lead-Acid Battery Hybrid Electric Vehicle J. Solano; S. Jemei; L. Boulon; L. Silva; D. Hissel; M.C. Pera 2019 |
|
|
IEEE VTS Motor Vehicles Challenge 2021-hnergy Management of A Dual-Motor All-Wheel Drive Electric Vehicle B.H. Nguyen; J.Pedro F. Trovao; S. Jemei; L. Boulon; A. Bouscayrol 2020 |
10.1109/VPPC49601.2020.9330915 |
|
If You Eat Too Much Fat, You Will Lose Your Sense of Smell G. Brand 2019 |
|
|
IFCT-1003 LADIE trial: Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC J. Mazieres; F. Barlesi; O. Molinier; I. Monnet; C. Audigier-Valette; B. Besse; A.C. Toffart; P.A. Renault; S. Hiret; S. Fraboulet-Moreau; B. Mennecier; P. Masson; V. Westeel; P.J. Souquet; E. Pichon; E. Amour; F. Morin; D. Moro-Sibilot 2016 |
10.1093/annonc/mdw383.85 |
|
IFCT-1003 LADIE trial: Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC. J. Mazieres; F. Barlesi; O. Molinier; I. Monnet; C. Audigier-Valette; B. Besse; A.Claire Toffart; P.A. Renault; P. Masson; B. Mennecier; S.Moreau Fraboulet; S. Hiret; V. Westeel; P. Dumont; A.B. Cortot; E. Pichon; M.Paule Lebitasy; F. Morin; G. Zalcman; F.Cooperativ Interg 2015 |
|
|
IFCT-1701 DICIPLE: A randomized phase III trial comparing continuation nivolumab-Ipilimumab doublet immunotherapy until progression versus observation in patients with PDL1-positive stage IV non-small cell lung cancer (NSCLC) after nivolumab-ipilimumab in G. Zalcman; A.C. Toffart; A.C.Madroszyk Flandin; O. Molinier; C. Dayen; T. Egenod; A. Dixmier; G. Leprieur; P. Masson; N. Cloarec; L. Thibonnier; L. Favier; D. Debieuvre; J. Mazieres; S. Van Hulst; E. Pichon; E. Amour; F. Morin; P.J. Souquet 2019 |
|
|
IFM (Intergroupe francophone du myelome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up T. Dejoie; D. Lakomy; H. Caillon; B. Pegourie; O. Decaux 2016 |
10.1684/abc.2016.1166 |
|
IFM (Intergroupe francophone du myelome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up T. Dejoie; D. Lakomy; H. Caillon; B. Pegourie; O. Decaux 2017 |
10.1684/hma.2017.1300 |
|
IFM2012-03 X. Leleu; G. Fouquet; L. Karlin; B. Kolb; M. Tiab; C. Araujo; N. Meuleman; J. Malfuson; P. Bourquard; P. Lenain; M. Roussel; A. Jaccard; M.O. Petillon; K. Belhadj-Merzoug; G. Lepeu; M.L. Chretien; J. Fontan; P. Rodon; A. Schmitt; F. Offner; L. Voillat; S. Cereja; F. Kuhnowski; S. Rigaudeau; O. Decaux; C. Humbrecht-Kraut; J. Frayfer; O. Fitoussi; D.Roos Weil; J.Claude Eisenmann; V. Dorvaux; E.G. Voog; C. Hulin; M. Attal; P. Moreau; T. Facon 2016 |
10.1182/blood.V128.22.2128.2128 |
|
IgA dominates the early neutralizing antibody response to SARS-CoV-2 D. Sterlin; A. Mathian; M. Miyara; A. Mohr; F. Anna; L. Claer; P. Quentric; J. Fadlallah; H. Devilliers; P. Ghillani; C. Gunn; R. Hockett; S. Mudumba; A. Guihot; C.E. Luyt; J. Mayaux; A. Beurton; S. Fourati; T. Bruel; O. Schwartz; J.M. Lacorte; H. Yssel; C. Parizot; K. Dorgham; P. Charneau; Z. Amoura; G. Gorochov 2021 |
10.1126/scitranslmed.abd2223 |
|
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-alpha blockers C. Rasmussen; V. Abitbol; K.El Karoui; A. Bourrier; R. Paule; L. Vuitton; F. Maurier; D. Laharie; M. Fumery; C. Agard; M. Collins; S. Nancey; C. Rafat; A.G. Kervegant; V. Queyrel-Moranne; G. Moulis; B. Pigneur; A. Regent; C. Gay; C. Morbieu; C.Audrey Durel; D. Ducloux; F. Aubin; M. Voicu; N. Joher; T. Szwebel; M.C.Martinez Vinson; S. Koch; L. Guillevin; L. Peyrin-Biroulet; B. Terrier; G.Francais E. GFE; G.Etud Thera I Submitted |
10.1093/rheumatology/keab662 |
|
IgG and EoE: Too Soon for a Paradigm Shift Away From IgE H. Philpott; S. Royce; S. Nandurkar; F. Thien; P. Gibson 2015 |
10.1053/j.gastro.2014.09.048 |
|
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury C. Lefaucheur; D. Viglietti; C. Bentlejewski; J.P.Duong van Huyen; D. Vernerey; O. Aubert; J. Verine; X. Jouven; C. Legendre; D. Glotz; A. Loupy; A. Zeevi 2016 |
10.1681/ASN.2014111120 |
|
IgM Donor Specific Antibodies Are Frequently Associated with C1q-binding DnDSA in Renal Transplant Recipients. J. Bamoulid; A. Roodenburg; O. Staeck; C. Schoenemann; N. Lachmann; K. Budde 2016 |
|
|
Ikeda-like chaos on a dynamically filtered supercontinuum light source Y.K. Chembo; M. Jacquot; J.M. Dudley; L. Larger 2016 |
10.1103/PhysRevA.94.023847 |
|
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951 E. Clappier; N. Grardel; M. Bakkus; J. Rapion; B. De Moerloose; P. Kastner; A. Caye; J. Vivent; V. Costa; A. Ferster; P. Lutz; F. Mazingue; F. Millot; D. Plantaz; G. Plat; E. Plouvier; M. Poiree; N. Sirvent; A. Uyttebroeck; K. Yakouben; S. Girard; N. Dastugue; S. Suciu; Y. Benoit; Y. Bertrand; H. Cave; E.O.R.T.C. -CLG 2015 |
10.1038/leu.2015.134 |
|
IL-1RAP, a candidate for CAR T-cell immunotherapy M.Neto Da Rocha; R. Trad; W. Warda; R. Haderbache; L. Bouquet; C. Nicod; M. Deschamps; C. Ferrand 2019 |
10.1051/medsci/2019105 |
|
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4(+) Central Memory T Cells in a Macrophage Migration Inhibitory Factor Dependent Manner R. Loyon; E. Picard; O. Mauvais; L. Queiroz; V. Mougey; J.R. Pallandre; J. Galaine; P. Mercier-Letondal; G. Kellerman; N. Chaput; J. Wijdenes; O. Adotevi; C. Ferrand; P. Romero; Y. Godet; C. Borg 2016 |
10.4049/jimmunol.1501147 |
|
IL-23/Th17 targeted therapies in SAPHO syndrome. A case series D. Wendling; F. Aubin; F. Verhoeven; C. Prati 2017 |
10.1016/j.jbspin.2017.05.016 |
|
IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production S. Vigne; F. Chalmin; D. Duc; A.S. Clottu; L. Apetoh; J.M.A. Lobaccaro; I. Christen; J. Zhang; C. Pot 2017 |
10.3389/fimmu.2017.01184 |
|
IL-33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort P.C. Schroeder; V.I. Casaca; S. Illi; M. Schieck; S. Michel; A. Boeck; C. Roduit; R. Frei; A. Lluis; J. Genuneit; P. Pfefferle; M. Roponen; J. Weber; C. Braun-Fahrlander; J. Riedler; R. Lauener; D.Angele Vuitton; J.C. Dalphin; J. Pekkanen; E. von Mutius; M. Kabesch; B. Schaub; P.A.S.T.U.R.E.Study Grp 2016 |
10.1111/pai.12597 |